Psychedelic Research

Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
Missouri Allocates $5M For Psilocybin Research To Treat Opioid Addiction
Long-Term Medical Cannabis Use Has No Significant Harmful Effects On Memory Or Impulse Control, New Study Says
Missouri Allocates $5M For Psilocybin Research To Treat Opioid Addiction
Long-Term Medical Cannabis Use Has No Significant Harmful Effects On Memory Or Impulse Control, New Study Says
Ultra-Low-Dose Ketamine May Offer Relief For Opioid Withdrawal, Study Finds
Magic Mushrooms Boosted Humanity's Evolutionary Success, New Study Says: Did Psilocybin Make Early Humans Better Hunters?

Psychedelic Research Recent News

PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract
PharmAla Biotech partners with Johns Hopkins to supply MDMA for clinical trials, terminates contract with Red Light Holland, and presents new APA-01 research at the EBPS Workshop.
Moxy: The Short, Intense Psychedelic High Sweeping The Globe
Moxy, a powerful psychedelic, is gaining global momentum. With new FDA approved trials investigating its potential to treat mental health conditions, Moxy is poised to become a key player in the psychedelic space.
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
Psilera's trip-free psilocybin drug PSIL-006 clears key safety milestone, potentially offering a breakthrough treatment for frontotemporal dementia.
How Set And Setting Impact The Effects Of LSD, New Study Sheds Light
New research finds that LSD effects are shaped by dose, mood, and personality traits, offering insights into optimizing psychedelic therapy.
Psychedelic Therapy Needs To Move Beyond Mystical Experiences, Say Researchers In New Study
Explore new insights into the therapeutic potential of psychedelics beyond mystical experiences and their impact on clinical outcomes.
Single-Dose Psilocybin Therapy Shows Promise For Treating Alcohol Use Disorder, Study Finds
New study shows single-dose psilocybin therapy may reduce alcohol consumption in alcohol use disorder patients, offering a promising new treatment approach.
Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
MAPS funds a $200K pilot study at Emory University exploring the synergy between MDMA-assisted therapy and Massed Exposure Therapy for PTSD.
Psychedelic Trips Resemble Near-Death Experiences, New Study Shows—What Does It Mean?
New research highlights significant overlap between near-death experiences and those induced by psychedelic drugs, offering fresh insights into the nature of consciousness.
Psychedelics Enhance Creativity After Use, But MDMA Disrupts Memory, Study Shows
New research reveals distinct cognitive effects of psychedelics and MDMA, showing that psychedelics may impair focus but boost creativity, while MDMA primarily disrupts memory.
LSD's Potential In Pain Management: New Research Sheds Light On Psychedelic's Influence On Brain Networks
New research reveals how LSD alters brain networks involved in pain processing, offering potential insights for future pain management strategies.
MDMA Therapy Papers Retracted Amid Ethical Concerns At Lykos Study Site
Psychopharmacology retracts MDMA therapy papers due to ethical misconduct, while Lykos Therapeutics faces FDA rejection for PTSD treatment application.
New Tool Tracks Psychedelic Effects In Brain Neurons In Minutes Rather Than Hours
UC Davis researchers develop CaST, a rapid tool to track neurons affected by psychedelics, offering new insights into treatments for depression and PTSD.
FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety
FDA approves Incannex's Phase 2 trial for psilocybin-assisted psychotherapy in treating generalized anxiety disorder, following a successful review of the IND application.
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Can Psychedelics Increase Sexual Interest And Satisfaction? Study Says Yes And Effects Can Last Months
US Universities Ride The Psychedelics Wave With New Programs In Their Medical Schools
West Coast’s New Psychedelics & Neurotherapeutics Institute The University of California (UC) Davis launched the Institute for Psychedelics and Neurotherapeutics to further knowledge of how psychedelics work and produce safe and effective treatments for a range of mental health conditions. 
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants.
EXCLUSIVE: MAPS To Host Major Psychedelics Event In 2023, Speakers & Details Below
The Multidisciplinary Association for Psychedelic Studies (MAPS) has shared details for its Psychedelic Science 2023 event taking place next June 19 to 23 in Denver, Colorado. 
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon
UCSF Launches New Psychedelic Research Division
This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved